Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy
出版年份 2014 全文链接
标题
Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 39, Issue 12, Pages 1363-1375
出版商
Wiley
发表日期
2014-04-23
DOI
10.1111/apt.12764
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Review article: HCV genotype 3 - the new treatment challenge
- (2014) J. Ampuero et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection
- (2014) R. S. Koff ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy
- (2013) Karine Lacombe et al. AIDS
- Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients
- (2013) D. Joshi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
- (2013) Jürgen K Rockstroh et al. BMC Medicine
- Telaprevir in the Treatment of Acute Hepatitis C Virus Infection in HIV-Infected Men
- (2013) D. S. Fierer et al. CLINICAL INFECTIOUS DISEASES
- Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial
- (2013) Stefan Zeuzem et al. GASTROENTEROLOGY
- Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: The randomized PILLAR study
- (2013) Michael W. Fried et al. HEPATOLOGY
- Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial
- (2013) Mark S. Sulkowski et al. HEPATOLOGY
- Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial
- (2013) Mark S. Sulkowski et al. HEPATOLOGY
- Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics
- (2013) Anuoluwapo Osinusi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1-infected patients in Japan: the DRAGON study
- (2013) Norio Hayashi et al. JOURNAL OF GASTROENTEROLOGY
- 817 RANDOMISED CONTROLLED TRIAL OF 24 AND 48 WEEKS OF PEGYLATED INTERFERON alfa 2a PLUS RIBAVIRIN IN PATIENTS WITH GENOTYPE 3 HCV AND CIRRHOSIS
- (2013) G. Foster et al. JOURNAL OF HEPATOLOGY
- 1413 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL
- (2013) M. Manns et al. JOURNAL OF HEPATOLOGY
- 1425 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL
- (2013) I. Jacobson et al. JOURNAL OF HEPATOLOGY
- Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience
- (2013) Audrey Coilly et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
- (2013) Kris V Kowdley et al. LANCET
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
- (2013) Eric Lawitz et al. LANCET INFECTIOUS DISEASES
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Genotype 1 HCV Infection in the HIV Coinfected Patient in 2014
- (2013) Cody A. Chastain et al. Current HIV/AIDS Reports
- UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients
- (2012) P. Ramachandran et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents - A potentially lethal cocktail
- (2011) Michael Charlton HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search